- Home
- FBIO vs ORMP Comparison
FBIO vs ORMP Comparison
Compare FBIO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- ORMP
- Stock Information
- Founded
- FBIO 2006
- ORMP 2002
- Country
- FBIO United States
- ORMP United States
- Employees
- FBIO N/A
- ORMP N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- ORMP Health Care
- Exchange
- FBIO Nasdaq
- ORMP Nasdaq
- Market Cap
- FBIO 88.7M
- ORMP 104.6M
- IPO Year
- FBIO N/A
- ORMP N/A
- Fundamental
- Price
- FBIO $2.56
- ORMP $2.36
- Analyst Decision
- FBIO Strong Buy
- ORMP
- Analyst Count
- FBIO 2
- ORMP 0
- Target Price
- FBIO $16.50
- ORMP N/A
- AVG Volume (30 Days)
- FBIO 1.0M
- ORMP 116.9K
- Earning Date
- FBIO 11-13-2025
- ORMP 11-07-2025
- Dividend Yield
- FBIO N/A
- ORMP N/A
- EPS Growth
- FBIO N/A
- ORMP N/A
- EPS
- FBIO N/A
- ORMP N/A
- Revenue
- FBIO $59,301,000.00
- ORMP $2,000,000.00
- Revenue This Year
- FBIO $31.85
- ORMP N/A
- Revenue Next Year
- FBIO $44.43
- ORMP N/A
- P/E Ratio
- FBIO N/A
- ORMP N/A
- Revenue Growth
- FBIO N/A
- ORMP N/A
- 52 Week Low
- FBIO $1.33
- ORMP $1.82
- 52 Week High
- FBIO $4.20
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- FBIO 38.92
- ORMP 50.60
- Support Level
- FBIO $2.47
- ORMP $2.31
- Resistance Level
- FBIO $2.61
- ORMP $2.45
- Average True Range (ATR)
- FBIO 0.14
- ORMP 0.11
- MACD
- FBIO -0.05
- ORMP -0.00
- Stochastic Oscillator
- FBIO 20.93
- ORMP 60.76
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.